GlassScriptPhysician profile
Christopher Bret Kruthoff
NPI 1326425364
$3,052.29
in general payments reported to CMS, 2019-2025
20 companies · $1,000 in 2025
The $1,000 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $609 · 2020: $46.47 · 2022: $200 · 2023: $59.93 · 2024: $1,137 · 2025: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,156 · Food and Beverage: $1,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,156.25 |
| Food and Beverage | $1,040.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Research LLC | $750.00 | 2024 | |
| Glaukos Corporation | $406.25 | 2025 | Kxl System |
| Biotissue Holdings INC. | $341.34 | 2024-2025 | |
| Allergan, INC. | $339.97 | 2019-2022 | |
| Dompe US, INC. | $180.18 | 2024 | Oxervate |
| Sun Pharmaceutical Industries INC. | $166.42 | 2022-2023 | Cequa |
| Carl Zeiss Meditec USA, INC. | $158.85 | 2025 | Cirrus Hd-Oct |
| Abbvie INC. | $125.33 | 2025 | |
| Genzyme Corporation | $104.22 | 2019 | |
| Quidel Corporation | $77.65 | 2019 | |
| Aerie Pharmaceuticals, INC. | $76.71 | 2019-2020 | |
| Alcon Vision LLC | $72.77 | 2023-2025 | Clareon, Rocklatan |
| Harrow Eye, LLC | $60.00 | 2025 | Vevye |
| Novartis Pharmaceuticals Corporation | $49.17 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $37.92 | 2025 | Amo Phaco Needle |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $32.01 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Shire North American Group INC | $19.63 | 2019 | |
| Mallinckrodt Enterprises LLC | $19.41 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.66 | 2019 | |
| Oyster Point Pharma, INC. | $15.80 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Kruthoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.